Correlates and consequences of venous thromboembolism: The iowa women's health study

American Journal of Public Health

Volumn 100, Issue 8, 2010, Pages 1506-1513

  Lutsey, Pamela L ^a   Virnig, Beth A ^a   Durham, Sara B ^a   Steffen, Lyn M ^a   Hirsch, Alan T ^c   Jacobs Jr , David R ^a,b   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c ABBOTT NORTHWESTERN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ARTICLE; CAUSE OF DEATH; DIABETES MELLITUS; EDUCATIONAL STATUS; ESTROGEN THERAPY; EXERCISE; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; LIFESTYLE; MEDICAL RECORD; MEDICARE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SMOKING; STATISTICS; UNITED STATES; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

AGE DISTRIBUTION; AGED; ANTHROPOMETRY; CAUSE OF DEATH; DIABETES COMPLICATIONS; EDUCATIONAL STATUS; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; IOWA; LIFE STYLE; MEDICAL RECORD LINKAGE; MEDICARE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SMOKING; UNITED STATES; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

EID: 77954481628     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.157776     Document Type: Article

References (55)

1. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:14-18.
2. Bisgard KM, Folsom AR, Hong CP, Sellers TA. Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. Am J Epidemiol. 1994;139(10):990-1000.
3. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer-related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732-748.
4. Gornick ME, Warren JL, Eggers PW, et al. Thirty years of Medicare: impact on the covered population. Health Care Financ Rev. 1996;18(2):179-237.
5. Virnig BA. Marshall McBean A, Kind S, Dhoiakia R. Hospice use before death: variability across cancer diagnoses. Med Care. 2002;40(1):73-78.
6. Virnig BA, McBean M. Administrative data for public health, surveillance and planning. Annu Rev Public Health. 2001;22:213-230.
7. Kushi LH, Fee RM, Folsom AR, Mink PJ, Anderson KE, Sellers TA. Physical activity and mortality in postmenopausal women. JAMA. 1997;277(16):1287-1292.
8. Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ. Accuracy and reliability of self-measurement of body girths. Am J Epidemiol. 1988;128(4):740-748.
9. Cushinan M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the Longitudinal Investigation of Thromboembolism Etiology. Am J Med. 2004; 117(1): 19-25.
10. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998;128(9):737-740.
11. Heckbert SR, Kooperberg C, Safford MM, et al. Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Womem's Health Initiative. Am J Epidemiol 2004;160(12):1152-1158.
12. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonaiy embolism and deep venous thrombosis in the elderly. Arch Mem Med. 1994; 154(8):861.-866.
13. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005;43(5):480-485.
14. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organization; 1980.
15. White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost. 2005;93(2):298-305.
16. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital, incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991 ;151 (5):933-938.
17. Nordstrom M, Lindblad B, Bergqyist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232(2):155-160.
18. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158(6):585-593.
19. Oger E. Incidence of venous thromboembolism: a community-based study in western France. Thromb Haemost. 2000;83(5):657-660.
20. Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population: "the Study of Men Born in 1913." Arch Intern Med. 1997;157(15):1665-1670.
21. Folsom AR, Wu KK, Conlan MG, et al. Distributions of hemostatic variables in Blacks and Whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis. 1992;2(1):35-46.
22. White RH. Zhou. H, Gage BF. Effect of age on the incidence of veinous thromboembolism after major surgery. J Thromh Haemost. 2004;2(8):1327-1333.
23. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein, thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002;162(11):1245-1248.
24. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999; 159(5): 445-453.
25. Prandoni P, Lensing AWA, Cogo A, et al. The longterm clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125(1):1-7.
26. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353(9162):1386-1389.
27. Siddique RM, Siddique MI, Connors AF Jr, Rimm AA. Thirty-day case-fatality rates for pulmonary embolism in the elderly. Arch Intern Med. 1996;156(20): 2343-2347.
28. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study, Arch Intern Med. 2000; 160(6):761-768.
29. Hansson P-O, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160(6): 769-774.
30. Laczkovies C, Grafenhofer H, Kaider A, et al. Risk of recurrence after a first venous thromboembolic event in young women. Haematologica 2007;92(9):1201-1207.
31. Oakeis MJ, Kaufman JS. Methods in Social Epidemiology. San Francisco, CA: Jossey-Bass; 2006.
32. McLaren L. Socioeconomic status and obesity. Epidemiol Rev. 2007;29:29-48.
33. Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997;277(8):642-645.
34. Hansson P-O, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the Study of Mem Born in 1913." Arch Intern Med. 1999;159(16):1886-1890.
35. Pomp ER, Rosendaal FR, Doggen CJ. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol. 2008;83(2):97-102.
36. Glynn RJ, Rosnei- B. Comparison of risk, factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005:162(10): 975-982.
37. Goldhaber SZ, Savage DD, Garrison RJ, et al. Risk factors for pulmonary embolism: the Framingham Study. Am J Med. 1983;74(6):1023-1028.
38. Cogo A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994; 154(2): 164-168.
39. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the Longitudinal Investigation of Thromboembolism Etiology. Arch Intern Med 2002;162(10):1182-1189.
40. Saarinen J, Laurikka J, Sisto T, Tarkka M, Hakama M. The incidence and cardiovascular risk, indicators of deep venous thrombosis. Vasa. 1999;28(3):195-198.
41. Lee KW, Lip GYH. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 2003;163(19):2368- 2392.
42. De Cicco M. The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol. 2004;50(3):187-196.
43. Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res. 2001;102(6):V215-V224.
44. van Stralen KJ, Doggen CJ, Lumley T, et al. The relationship between exercise and risk of venous thrombosis in elderly people. J Am Geriatr Soc. 2008;56(3): 517-522.
45. van Stralen KJ, Le Cessio S, Rosendaal. FR, Doggen CJ. Regular sports activities decrease the risk of vemous thrombosis. J Thromh Haemost. 2007;5(11):2186-2192.
46. Cushman. M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62-69.
47. Darvall KAL, Sam RC, Silverman SH, Bradbury AW, Adam DJ. Obesity and thrombosis. Eur J Vasc Endovasc Surg. 2007;33(2):223-233.
48. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med. 2000; 132(9):689-696.
49. Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292(13): 1573-1580.
50. Simon T, De Jonage-Canonico MBY, Oger E, et al. Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost 2006;4(1):71-76.
51. Schneider DJ. Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coron Artery Dis. 2005:16(8):473-476.
52. Banga JD. Coagulation and fibrinolysis in diabetes. Semin Vasc Med. 2002;2(1):75-86.
53. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson J. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48(5):1017-1021.
54. de Lissovoy G. Economic issues in the treatment and prevention of deep vein thrombosis from a managed care perspective. Am J Manag Care. 2001;7(suppl 17): S535-S538.
55. The Surgeon General's Call to Action to Prevent Deep Vem Thrombosis and Pulmonary Embolism. Washington, DC: US Dept of Health and Human Services; 2008.